Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation

Blocking inhibitory factors within CNS demyelinating lesions is regarded as a promising strategy to promote remyelination. Bone morphogenetic protein 4 (BMP4) is an inhibitory factor present in demyelinating lesions. Noggin, an endogenous antagonist to BMP, has previously been shown to increase the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:eNeuro
Main Authors: Govier-Cole, Alistair E., Wood, Rhiannon J., Fletcher, Jessica L., Gonsalvez, David G., Merlo, Daniel, Cate, Holly S., Murray, Simon S., Xiao, Junhua
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2019
Assuntos:
New Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6529590/
https://ncbi.nlm.nih.gov/pubmed/31028086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/ENEURO.0399-18.2019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados